Zhijian Wang
-
- Cardiovascular Disease and Adiposity 2
-
- Autophagy in Disease and Therapy 4
-
- Coronary Interventions and Diagnostics 5
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 2
-
- Epigenetics and DNA Methylation 3
-
- Vascular Procedures and Complications 3
-
- Virus-based gene therapy research 2
-
- Atherosclerosis and Cardiovascular Diseases 2
- Journals
- PLoS ONE (1 paper)Medicine (2 papers)American Journal of Physiology-Renal Physiology (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Zhijian Wang
25 papers receiving 327 citations
Peers
Comparison fields: 5 of 69
- Cardiology and Cardiovascular Medicine 86
- Epidemiology 125
- Internal Medicine 12
- Emergency Medical Services 18
- Hematology 23
Countries citing papers authored by Zhijian Wang
This map shows the geographic impact of Zhijian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijian Wang more than expected).
Fields of papers citing papers by Zhijian Wang
This network shows the impact of papers produced by Zhijian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijian Wang. The network helps show where Zhijian Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhijian Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2022 | 5 | |
| 3 | 2020 | 3 | |
| 4 | 2018 | 43 | |
| 5 | 2017 | 4 | |
| 6 | 2017 | 29 | |
| 7 | 2017 | 11 | |
| 8 | 2015 | 28 | |
| 9 | 2015 | 54 | |
| 10 | 2014 | 29 | |
| 11 | 2014 | 9 | |
| 12 | 2014 | 19 | |
| 13 | [Treating coronary heart disease by acupuncture at neiguan (PC6) and xinahu (BL15): an efficacy assessment by SPECT]. | 2013 | 5 |
| 14 | 2012 | 7 | |
| 15 | Safety and feasibility of repeated percutaneous transradial coronary intervention in the same route. | 2012 | 6 |
| 16 | [Randomized study on T stenting and small protrusion technique versus simple stenting for patients with coronary artery bifurcation lesions and with big size side branch]. | 2010 | 3 |
| 17 | 2010 | 5 | |
| 18 | 2009 | 13 | |
| 19 | [Expression of chemokine-like factor 2(CKLF2) mRNA in rat myocardium with hypertrophy]. | 2004 | 1 |
| 20 | Effect of total glucoside of Paeony on rheumatoid orthris patients | 1994 | 3 |
About Zhijian Wang
Zhijian Wang is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Complementary and alternative medicine, having authored 26 papers that have together received 333 indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (5 papers), Autophagy in Disease and Therapy (4 papers), Epigenetics and DNA Methylation (3 papers), Vascular Procedures and Complications (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers), Virus-based gene therapy research (2 papers), Cardiovascular Disease and Adiposity (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (86 citations), Epidemiology (125 citations) and Internal Medicine (12 citations). Zhijian Wang has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Yingxin Zhao, Chunxiao Wang, Qian Ma, Changlong Li, Juan Bai, Yufeng Li, Xianwei Wang, Zhongbao Song, Qianyu Liu and Suping Zhang. Their work appears in journals such as PLoS ONE, Medicine and American Journal of Physiology-Renal Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.